Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology
Nicole Pfarr(Technical University of Munich), Albrecht Stenzinger(Heidelberg University), Moritz Jesinghaus(Philipps University of Marburg), Roland Penzel(Heidelberg University), Carsten Denkert(Philipps University of Marburg), Aurelia Noske(University Hospital of Zurich), Silvia Darb‐Esfahani(Humboldt-Universität zu Berlin), Eliane T. Taube(Charité - Universitätsmedizin Berlin), Elena Ioana Braicu, Volker Endris(Heidelberg University), Peter Schirmacher(Heidelberg University), Melanie Boxberg(Starnberg Hospital), Jonas Leichsenring(Heidelberg University), Wilko Weichert(Deutsches Konsortium für Translationale Krebsforschung)
Cited by 27
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k